Issue 15, 2021

Hydrogen sulfide triggered molecular agent for imaging and cancer therapy

Abstract

We developed an activatable molecular reagent, PNF, triggered by intracellular H2S in the lysosome to release the therapeutic drug amonafide, which can escape from the lysosome into the nucleus to induce autophagy of cancer cells. PNF exhibits potent inhibitory activity against cisplatin-resistant tumor cell lines.

Graphical abstract: Hydrogen sulfide triggered molecular agent for imaging and cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
08 Dec 2020
Accepted
20 Jan 2021
First published
21 Jan 2021

Chem. Commun., 2021,57, 1931-1934

Hydrogen sulfide triggered molecular agent for imaging and cancer therapy

C. Ge, X. Di, S. Han, M. Wang, X. Qian, Z. Su, H. Liu and Y. Qian, Chem. Commun., 2021, 57, 1931 DOI: 10.1039/D0CC07982K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements